Stockscreener 앱 받기
377.05
1.77%
-6.79
시장 영업 전:
375.05
-2.00
-0.53%
전일 마감가:
$383.84
열려 있는:
$382.31
하루 거래량:
1.77M
Relative Volume:
1.02
시가총액:
$85.19B
수익:
$183.12B
순이익/손실:
$5.92B
주가수익비율:
14.71
EPS:
25.63
순현금흐름:
$3.67B
1주 성능:
+1.28%
1개월 성능:
-8.03%
6개월 성능:
-8.12%
1년 성능:
-29.98%
1일 변동 폭
$374.25
$385.89
1주일 범위
$368.83
$389.40
52주 변동 폭
$357.45
$567.26
엘리번스 헬스 Stock (ELV) Company Profile
명칭
Elevance Health Inc
전화
(800) 331-1476
주소
220 VIRGINIA AVENUE, INDIANAPOLIS
ELV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
377.05 | 84.95B | 183.12B | 5.92B | 3.67B | 25.63 |
|
UNH
Unitedhealth Group Inc
|
304.72 | 267.61B | 410.06B | 22.11B | 24.86B | 23.88 |
|
CI
Cigna Group
|
314.99 | 84.22B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
63.60 | 77.60B | 378.96B | 5.28B | 5.94B | 4.19 |
|
HUM
Humana Inc
|
231.39 | 27.35B | 117.76B | 1.21B | 2.39B | 9.95 |
엘리번스 헬스 Stock (ELV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-15 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | 업그레이드 | Argus | Hold → Buy |
| 2025-01-22 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | 다운그레이드 | Argus | Buy → Hold |
| 2024-07-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-06-24 | 개시 | Morgan Stanley | Overweight |
| 2024-05-30 | 개시 | Robert W. Baird | Outperform |
| 2024-03-06 | 개시 | Barclays | Overweight |
| 2023-07-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-03-28 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-08-22 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
모두보기
엘리번스 헬스 주식(ELV)의 최신 뉴스
Elevance Health (NYSE:ELV) Price Target Cut to $480.00 by Analysts at Barclays - Defense World
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance Health, and Iovance and Encourages Investors to Contact the Firm - TradingView
Beyond The Numbers: 9 Analysts Discuss Elevance Health Stock - Benzinga
Deadline Alert: Elevance Health, Inc. (ELV) Investors Who - GlobeNewswire
Deadline Alert: Elevance Health, Inc. (ELV) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - TradingView
Barclays Adjusts Price Target for Elevance Health (ELV) | ELV St - GuruFocus
Barclays Adjusts Elevance Health (ELV) Price Target Amid Medicare Concerns | ELV Stock News - GuruFocus
ELV Shareholders Have the Right to Lead the Elevance Health, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsELV - PR Newswire
How Is Elevance Health's Stock Performance Compared to Other Healthcare Services Stock? - Barchart.com
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Elevance Health, - GlobeNewswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV - TradingView
ELV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elevance Health, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesELV - WV News
Not Many Are Piling Into Elevance Health, Inc. (NYSE:ELV) Just Yet - simplywall.st
Insiders At Elevance Health Sold US$6.9m In Stock, Alluding To Potential Weakness - Yahoo Finance
ELV CLASS NOTICE: Elevance Health, Inc. Investors may have - GlobeNewswire
Cantor Fitzgerald Reiterates ‘Overweight’ Rating on Elevance Health (ELV) - MSN
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit - marketscreener.com
DEADLINE ALERT for WST, DMRC, CODI, ELV: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - GlobeNewswire Inc.
ELV Investors Have the Opportunity to Lead the Elevance Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - PR Newswire
ELV REMINDER: BFA Law Reminds Elevance Health, Inc. - GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Elevance - GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV - TradingView
Elevance Health, Inc. (ELV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
ELEVANCE HEALTH (NYSE: ELV) INVESTOR ALERT: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action - Eastern Progress
Elevance Health: A Bargain At 11x Earnings (NYSE:ELV) - Seeking Alpha
Elevance sues providers, HaloMD over No Surprises Act allegations - Modern Healthcare
ELV Investors Have the Opportunity to Lead the Elevance Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - GlobeNewswire
Elevance Looks Cheap Now: But is it Time to Buy or Dodge? - TradingView
Why Elevance Health Shares Are Surging Premarket On Wednesday? - Benzinga
Elevance Health Reaffirms 2025 Earnings Guidance Of $28.30-$29.00 Per ShareSEC Filing - marketscreener.com
Elevance Health (ELV) Reaffirms 2025 Earnings Guidance Amid Inve - GuruFocus
Elevance Health Reaffirms 2025 Earnings Guidance - TipRanks
Elevance Health maintains 2025 earnings guidance - Investing.com
Elevance Health maintains 2025 earnings guidance By Investing.com - Investing.com UK
ELV Class Action Lawsuit – Shareholders Should Contact - GlobeNewswire
ELV Class Action Lawsuit – Shareholders Should Contact Robbins LLP for Information About Leading the Class Action Against Elevance Health, Inc. - TradingView
ELV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Investors who lost money with shares of Elevance Health, Inc. - openPR.com
ELV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elevance Health, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health - StreetInsider
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GuruFocus
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Elevance - GlobeNewswire
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV - TradingView
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure ... - Bluefield Daily Telegraph
ELV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance - StreetInsider
ELV FRAUD: Suffer Losses on Elevance Health, Inc.? You may - GlobeNewswire
ELV FRAUD NOTICE: Elevance Health, Inc. Investors with Losses are Reminded to Contact BFA Law about the Pending Securities Fraud Class Action - Newsfile
Elevance Health, Inc. (NYSE:ELV) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Elevance Health Inc. stock underperforms Friday when compared to competitors - MarketWatch
엘리번스 헬스 (ELV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
자본화:
|
볼륨(24시간):